Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1: genes and variants
Explore variant evidence for Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 across 1 analyzed protein (RUNX1). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 37 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
RUNX1: Runt-related transcription factor 1
It controls hematopoietic stem-cell emergence and later megakaryocytic and myeloid differentiation through lineage-specific transcriptional programs. Germline loss-of-function variants cause familial platelet disorder with myeloid malignancy predisposition, while somatic mutations and fusions are common in leukemia.
3 ClinVar pathogenic / likely pathogenic and 37 uncertain variants in RUNX1 have source records linked to Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| RUNX1 S67R | 67 | Runt | Pathogenic / likely pathogenic (★★★) |
| RUNX1 H78P | 78 | Runt | Pathogenic / likely pathogenic (★★★) |
| RUNX1 R142I | 142 | Runt | Pathogenic / likely pathogenic (★★★) |
Same protein, different disease
- Hereditary thrombocytopenia and hematologic cancer predisposition syndrome also has ClinVar records linked to RUNX1 variants; they fall partly in the same places as the Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 variants (39 pathogenic / likely pathogenic).
Diseases related to Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
- Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, also linked to RUNX1
- Acute myeloid leukemia, also linked to RUNX1
Frequently asked questions
Which genes have records linked to Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1?
This view contains 1 analyzed proteins: RUNX1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 37 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 66 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center